A scientist at heart with a passion for innovation and creativity, Erin Daly is an accomplished patent professional who helps clients develop, protect, and monetize their intellectual property assets. Her combination of hands-on scientific expertise, in-house experience, and legal insight have made her a valued and trusted advisor and effective advocate on a wide range of patent matters.

Erin’s practice extends to every stage of the patent lifecycle. She works closely and seamlessly with her clients’ business, scientific, and legal teams to identify patentable subject matter and develop effective and efficient patent prosecution strategies. She has extensive experience and a lengthy record of success preparing, drafting, and prosecuting patents before the USPTO and crafts meticulous legal opinions with respect to patentability, validity, and freedom to operate.

Before JMIN

Serving for several years as in-house intellectual property counsel for a global clinical-stage biotechnology company, Erin has managed an international team of outside patent counsel, overseen the worldwide prosecution of patent applications, and led IP due diligence on complex and consequential business transactions. This experience has imbued Erin with an appreciation of her clients’ priorities and pressures and given her an understanding of what they need—and what they don’t—from outside patent counsel. With efficiency and transparency, she provides clear, thorough deliverables that give decision-makers and other constituencies the actionable information and guidance that can help them achieve their strategic business objectives.

Erin has extensive experience with preclinical and clinical programs across multiple technology platforms related to pharmaceuticals, biopharmaceuticals, chemical processes, drug delivery, chemical formulations, and crystallography. Exemplary technologies include novel chemical entities, including proteolysis targeting chimera (PROTAC®), antibody-drug conjugates, polymers, lipid nanoparticles, isotopically-labeled compounds, oligomers, and small molecules; solid forms of compounds, such as crystalline polymorphs; methods of organic synthesis, and methods of treating various types of cancer, microbial infections, pain, stroke, and neurodegenerative disorders (e.g., Alzheimer’s, Parkinson’s).

Practice Areas


  • J.D., Suffolk University Law School
  • B.S., Chemistry, Fairfield University
  • Ph.D., Organic Chemistry, University of Notre Dame


  • United States Patent and Trademark Office
  • Massachusetts